CSAT GPRA Tool _ 8-16-2022 _ Tracked

20220812 OE SPARS CSAT GPRA Tool_Track Changes Since prior OMB approval.docx

Government Performance and Results Act Client/Participant Outcome Measures

CSAT GPRA Tool _ 8-16-2022 _ Tracked

OMB: 0930-0208

Document [docx]
Download: docx | pdf

Form Approved

OMB No. 0930-0208

Expiration Date: 03/31/2025


Substance Abuse and Mental Health Services Administration (SAMHSA)



Center for Substance Abuse Treatment (CSAT)



Government Performance and Results Act (GPRA)

Client Outcome Measures for Discretionary Programs

August 2022


Public reporting burden for this collection of information is estimated to average 36 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information, if all items are asked of a client/participant; to the extent that providers already obtain much of this information as part of their ongoing client/participant intake or follow-up, less time will be required. Send comments regarding this burden estimate or any other aspect of this collection of information to SAMHSA Reports Clearance Officer, Room 15E57A, 5600 Fishers Lane, Rockville, MD 20857. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. The control number for this project is 0930-0208.






[This page intentionally left blank]













[This page intentionally left blank]




A. Record Management

Client ID |____|____|____|____|____|____|____|____|____|____|____|____|____|____|____|

Client Description by Grant Type:

Shape1 Treatment grant client

Shape2 Client in recovery grant

Contract/Grant ID |____|____|____|____|____|____|____|____|____|____|

Interview Type [CIRCLE ONLY ONE TYPE.]

Intake [GO TO INTERVIEW DATE.]

3-month follow-up [FOR SELECT PROGRAMS]

→ → → Did you conduct a follow-up interview? Shape3 Yes Shape4 No
[IF NO, GO DIRECTLY TO SECTION I.]

6-month follow-up → → → Did you conduct a follow-up interview? Shape5 Yes Shape6 No
[IF NO, GO DIRECTLY TO SECTION I.]

Discharge → → → Did you conduct a discharge interview? Shape7 Yes Shape8 No
[IF NO, GO DIRECTLY TO SECTION J.]

Interview Date |____|____| / |____|____| / |____|____|____|____|
Month Day Year




















A. Record Management - Demographics [Asked only at intake/baseline.]

  1. What is your birth month and year?

|____|____| / |____|____|____|____|
Month Year

Shape9 Refused

  1. What do you consider yourself to be?

Shape10 Male

Shape11 Female

Shape12 Transgender (Male to Female)

Shape13 Transgender (Female to Male)

Shape14 Gender non-conforming

Shape15 Other (Specify) _____________

Shape16 Refused

  1. Are you Hispanic, Latino/a, or of Spanish origin?

Shape17 Yes

Shape18 No [SKIP TO QUESTION 4]

Shape19 Refused [SKIP TO QUESTION 4]

3a. What ethnic group do you consider yourself? You may indicate more than one.

Shape20 Central American

Shape21 Cuban

Shape22 Dominican

Shape23 Mexican

Shape24 Puerto Rican

Shape25 South American

Shape26 Other (Specify)_____________

Shape27 Refused

  1. What is your race? You may indicate more than one.

Shape28 Black or African American

Shape29 White

Shape30 American Indian

Shape31 Alaska Native

Shape32 Asian Indian

Shape33 Chinese

Shape34 Filipino

Shape35 Japanese

Shape36 Korean

Shape37 Vietnamese

Shape38 Other Asian

Shape39 Native Hawaiian

Shape40 Guamanian or Chamorro

Shape41 Samoan

Shape42 Other Pacific Islander

Shape43 Other (Specify)_____________

Shape44 Refused

  1. Do you speak a language other than English at home?

  • Yes

  • No [SKIP TO QUESTION 6]

  • Refused [SKIP TO QUESTION 6]


5a. What is this language?


  • Spanish

  • Other (SPECIFY) ___________

  1. Do you think of yourself as… [You may indicate more than one.]

Shape45 Straight Or Heterosexual

Shape46 Homosexual (Gay Or Lesbian)

Shape47 Bisexual

Shape48 Queer, Pansexual, And/Or Questioning

Shape49 Asexual

Shape50 Other (SPECIFY) ___________________________________

Shape51 Refused

  1. What is your relationship status?

Shape52 Married

Shape53 Single

Shape54 Divorced

Shape55 Separated

Shape56 Widowed

Shape57 In a relationship

Shape58 In multiple relationships

Shape59 Refused

  1. Are you currently pregnant?

Shape60 Yes

Shape61 No

Shape62 Do not know

Shape63 Refused

  1. Do you have children? [Refers to children both living and/or who may have died]

Shape64 Yes

Shape65 No [SKIP TO QUESTION 10]

Shape66 Refused [SKIP TO QUESTION 10]

9a. How many children under the age of 18 do you have?

|____|____| Shape67  Refused

9b. Are any of your children, who are under the age of 18, living with someone else due to a court’s intervention? [THE VALUE IN ITEM A9b CANNOT EXCEED THE VALUE IN A9a.]

Shape68 Yes Number of children removed from client’s care |____|____|

Shape69 No [SKIP TO QUESTION 10]

Shape70 Refused [SKIP TO QUESTION 10]

9c. Have you been reunited with any of your children, under the age of 18, who have been previously removed from your care? [THE VALUE IN ITEM A9c CANNOT EXCEED THE VALUE IN A9a.]

Shape71 Yes Number of children with whom the client has been reunited |____|____|

Shape72 No

Shape73 Refused

  1. Have you ever served in the Armed Forces, in the Reserves, in the National Guard, or in other Uniformed Services? [IF SERVED] What area, the Armed Forces, Reserves, National Guard, or other did you serve?

Shape74 No

Shape75 Yes, In The Armed Forces

Shape76 Yes, In The Reserves

Shape77 Yes, In The National Guard

Shape78 Yes, Other Uniformed Services [Includes NOAA, USPHS]

Shape79 Refused

11. How long does it take you, on average, to travel to the location where you receive services provided by this grant?

Shape80 Half an hour or less

Shape81 Between half an hour and one hour

Shape82 Between one hour and one and a half hours

Shape83 Between one and a half hours and two hours

Shape84 Two hours or more

Shape85 Refused


b. SUBSTANCE uSE AND PLANNED SERVICES

1. Using the table below, please indicate the following:



  1. The number of days, in the past 30 days, that the client reports using a substance.

[DO NOT READ TO CLIENT] The client should be encouraged to list the substances on their own. If they are unsure, the list from the table below can be read to the client. Please note that not all substance use is considered harmful or illicit – it may be that a substance is prescribed by a licensed provider, or that the client uses the substance in accordance with official, national safety guidelines. In such instances, clarification from the client should be sought, but if the substance is only taken as prescribed or used on each occasion in accordance with official, national safety guidelines, then it is not considered misuse. If no use of a listed substance is reported, please enter a zero (‘0’) in the corresponding ‘Number of Days Used’ column. If the client refuses to answer the question, then select “”Refused.

  1. The route by which the substance is used.

[DO NOT READ TO CLIENT] Mark one route only for each substance used. But, if the client identifies more than one route, choose the corresponding route with the highest associated number value (numbers 1 – 6). Responses should capture the past 30 days of use.

During the past 30 days, how many days have you used any substance, and how do you take the substance?


Shape86 REFUSED



A. Number of Days Used

B. Route

1.

Oral

2.

Intranasal

3.

Vaping

4.

Smoking

5.

Non-IV Injection

6.

Intravenous (IV) Injection

0.

Other

a. Alcohol



1. Alcohol

|___|___|

|___|

2. Other (Specify)

|___|___|

|___|




b. Opioids



1. Heroin

|___|___|

|___|

2. Morphine

|___|___|

|___|

3. Fentanyl (Prescription Diversion Or Illicit Source)

|___|___|

|___|

4. Dilaudid

|___|___|

|___|

5. Demerol

|___|___|

|___|

6. Percocet

|___|___|

|___|

7. Codeine

|___|___|

|___|

8. Tylenol 2, 3, 4

|___|___|

|___|

9. OxyContin/Oxycodone

|___|___|

|___|

10. Non-prescription methadone

|___|___|

|___|

11. Non-prescription buprenorphine

|___|___|

|___|

12. Other (Specify)

|___|___|

|___|




c. Cannabis



1. Cannabis (Marijuana)

|___|___|

|___|

2. Synthetic Cannabinoids

|___|___|

|___|

3. Other (Specify)

|___|___|

|___|




d. Sedative, Hypnotic, or Anxiolytics



1. Sedatives

|___|___|

|___|

2. Hypnotics

|___|___|

|___|

3. Barbiturates

|___|___|

|___|

4. Anxiolytics/Benzodiazepines

|___|___|

|___|

5. Other (Specify)

|___|___|

|___|




e. Cocaine



1. Cocaine

|___|___|

|___|

2. Crack

|___|___|

|___|

3. Other (Specify)

|___|___|

|___|




f. Other Stimulants



1. Methamphetamine

|___|___|

|___|

2. Stimulant medications

|___|___|

|___|

3. Other (Specify)

|___|___|

|___|




g. Hallucinogens & Psychedelics



1. PCP

|___|___|

|___|

2. MDMA

|___|___|

|___|

3. LSD

|___|___|

|___|

4. Mushrooms

|___|___|

|___|

5. Mescaline

|___|___|

|___|

6. Salvia

|___|___|

|___|

7. DMT

|___|___|

|___|

8. Other (Specify)

|___|___|

|___|




h. Inhalants



1. Inhalants

|___|___|

|___|

2. Other (Specify)

|___|___|

|___|




i. Other Psychoactive Substances



1. Non-prescription GHB

|___|___|

|___|

2. Ketamine

|___|___|

|___|

3. MDPV/Bath Salts

|___|___|

|___|

4. Kratom

|___|___|

|___|

5. Khat

|___|___|

|___|

6. Other tranquilizers

|___|___|

|___|

7. Other downers

|___|___|

|___|

8. Other sedatives

|___|___|

|___|

9. Other hypnotics

|___|___|

|___|

10. Other (Specify)

|___|___|

|___|




j. Tobacco and Nicotine



1. Tobacco

|___|___|

|___|

2. Nicotine (Including Vape Products)

|___|___|

|___|

3. Other (Specify)

|___|___|

|___|



  1. Have you been diagnosed with an alcohol use disorder, if so which FDA-approved medication did you receive for the treatment of this alcohol use disorder in the past 30 days? [CHECK ALL THAT APPLY.]

Shape87 Naltrexone

[IF RECEIVED]

Specify how many days received

|___|___|

Shape88 Extended‒release Naltrexone

[IF RECEIVED]

Specify how many doses received

|___|___|

Shape89 Disulfiram

[IF RECEIVED]

Specify how many days received

|___|___|

Shape90 Acamprosate

[IF RECEIVED]

Specify how many days received

|___|___|

Shape91 Did not receive an FDA-approved medication for a diagnosed alcohol use disorder

Shape92 Client does not report such a diagnosis



  1. Have you been diagnosed with an opioid use disorder, if so which FDA-approved medication did you receive for the treatment of this opioid use disorder in the past 30 days? [CHECK ALL THAT APPLY.]

Shape93 Methadone

[IF RECEIVED]

Specify how many days received

|___|___|

Shape94 Buprenorphine

[IF RECEIVED]

Specify how many days received

|___|___|

Shape95 Naltrexone

[IF RECEIVED]

Specify how many days received

|___|___|

Shape96 Extended‒release Naltrexone

[IF RECEIVED]

Specify how many doses received

|___|___|

Shape97 Did not receive an FDA-approved medication for a diagnosed opioid use disorder

Shape98 Client does not report such a diagnosis


  1. Have you been diagnosed with a stimulant use disorder, if so which evidence-based interventions did you receive for the treatment of this disorder in the past 30 days? [CHECK ALL THAT APPLY.]

Shape99 Contingency Management

[IF RECEIVED]

Specify how many days received

|___|___|

Shape100 Community Reinforcement

[IF RECEIVED]

Specify how many days received

|___|___|

Shape101 Cognitive Behavioral Therapy

[IF RECEIVED]

Specify how many days received

|___|___|

Shape102 Other evidence-based intervention

[IF RECEIVED]

Specify how many days received

|___|___|

Shape103 Did not receive any intervention for a diagnosed stimulant use disorder

Shape104 Client does not report such a diagnosis


  1. Have you been diagnosed with a tobacco use disorder, if so which FDA-approved medication did you receive for the treatment of this tobacco use disorder in the past 30 days? [CHECK ALL THAT APPLY.]

Shape105 Nicotine Replacement

[IF RECEIVED]

Specify how many days received

|___|___|

Shape106 Bupropion

[IF RECEIVED]

Specify how many days received

|___|___|

Shape107 Varenicline

[IF RECEIVED]

Specify how many days received

|___|___|

Shape108 Did not receive an FDA-approved medication for a diagnosed tobacco use disorder

Shape109 Client does not report such a diagnosis


  1. In the past 30 days, did you experience an overdose or take too much of a substance that resulted in needing supervision or medical attention?

Shape110 Yes [IF YES, SPECIFY BELOW, IN QUESTION 7]

Shape111 No [IF NO, SKIP TO QUESTION 8]

Shape112 Refused [SKIP TO QUESTION 8]


  1. In the past 30 days, after taking too much of a substance or overdosing, what intervention did you receive? You may indicate more than one.

Shape113 Naloxone (Narcan)

Shape114 Care in an Emergency Department

Shape115 Care from a Primary Care Provider

Shape116 Admission to a hospital

Shape117 Supervision by someone else

Shape118 Other (Specify) ______________________________

Shape119 Refused


  1. Not including this current episode, how many times in your life have you been treated at an inpatient or outpatient facility for a substance use disorder?

Shape120 One time

Shape121 Two times

Shape122 Three times

Shape123 Four times

Shape124 Five times

Shape125 Six or more times

Shape126 Never [SKIP TO QUESTION 10]

Shape127 Refused [SKIP TO QUESTION 10]



  1. Approximately when was the last time you received inpatient or outpatient treatment for a substance use disorder?

Shape128 Less than 6 months ago

Shape129 Between 6 months and one year ago

Shape130 One to two years ago

Shape131 Two to three years ago

Shape132 Three to four years ago

Shape133 Five or more years ago

Shape134 Refused



  1. Have you ever been diagnosed with a mental health illness by a health care professional?

Shape135 Yes

Shape136 No [SKIP TO QUESTION 11]

Shape137 Refused [SKIP TO QUESTION 11]



10a. Please ask the client to self-report their mental health illnesses as listed in the table below. The client should be encouraged to report their own mental health illnesses but if preferred, the list can be read to the client. PLEASE INDICATE ALL THAT APPLY.




SELF-REPORTED

Schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders


Brief psychotic disorder

Delusional disorder

Schizoaffective disorders

Schizophrenia

Schizotypal disorder

Shared psychotic disorder

Unspecified psychosis

Mood [affective] disorders

Bipolar disorder

Major depressive disorder, recurrent


SELF-REPORTED

Major depressive disorder, single episode

Manic episode

Persistent mood [affective] disorders

Unspecified mood [affective] disorder

Phobic Anxiety and Other Anxiety Disorders

Agoraphobia without panic disorder

Agoraphobia with panic disorder

Agoraphobia, unspecified

Generalized anxiety disorder

Panic disorder

Phobic anxiety disorders

Social phobias (Social anxiety disorder)

Specific (isolated) phobias

Obsessive-compulsive disorders

Excoriation (skin-picking) disorder

Hoarding disorder

Obsessive-compulsive disorder

Obsessive-compulsive disorder with mixed obsessional thoughts and acts

Reaction to severe stress and adjustment disorders

Acute stress disorder; reaction to severe stress, and adjustment disorders

Adjustment disorders

Body dysmorphic disorder

Dissociative and conversion disorders

Dissociative identity disorder

Post traumatic stress disorder

Somatoform disorders

Behavioral syndromes associated with physiological disturbances and physical factors

Eating disorders

Sleep disorders not due to a substance or known physiological condition

Disorders of adult personality and behavior

Antisocial personality disorder

Avoidant personality disorder

Borderline personality disorder

Dependent personality disorder

Histrionic personality disorder

Intellectual disabilities

Obsessive-compulsive personality disorder

Other specific personality disorders

Paranoid personality disorder

Personality disorder, unspecified

Pervasive and specific developmental disorders

Schizoid personality disorder


    • NONE OF THE ABOVE

[FOLLOW-UP AND DISCHARGE INTERVIEWS: GO TO SECTION C. AT INTAKE, CONTINUE WITH THE FOLLOWING QUESTIONS]

11. Was the client screened by your program, using an evidence-based tool or set of questions, for co-occurring mental health and/or substance use disorders?

Shape138 Yes

Shape139 No [SKIP TO QUESTION 12]

11a. Did the client screen positive for co-occurring mental health and substance use
disorders?

Shape140 Yes

Shape141 No

11b. [IF YES TO QUESTION 11a] Was the client referred for further assessment for a co-occurring mental health and substance use disorder?

Shape142 Yes

Shape143 No


12. PLANNED SERVICES PROVIDED UNDER GRANT FUNDING [REPORTED BY PROGRAM STAFF ONLY AT INTAKE/BASELINE.]

Identify the services you plan to provide to the client during the client’s course of treatment/recovery. [MARK ONLY THE CIRCLE CORRESPONDING TO THE PLANNED SERVICE THAT WILL BE PROVIDED UNDER THE CURRENT GRANT. MARK ALL THAT APPLY IN EACH SECTION.]


Modality

[SELECT AT LEAST ONE MODALITY.]

1. Case Management Shape144

2. Intensive Outpatient Treatment Shape145

3. Inpatient/Hospital (Other Than Withdrawal Management) Shape146

4. Outpatient Therapy Shape147

5. Outreach Shape148

6. Medication

A. Methadone Shape149

B. Buprenorphine Shape150

C. Naltrexone – Short Acting Shape151

D. Naltrexone – Long Acting Shape152

E. Disulfiram Shape153

F. Acamprosate Shape154

G. Nicotine Replacement Shape155

H. Bupropion Shape156

I. Varenicline Shape157

7. Residential/Rehabilitation Shape158

8. Withdrawal Management (Select Only One)

A. Hospital Inpatient Shape159

B. Free Standing Residential Shape160

C. Ambulatory Detoxification Shape161

9. After Care Shape162

10. Recovery Support Shape163

11. Other (Specify) Shape164

[SELECT AT LEAST ONE SERVICE.]


Treatment Services

[SBIRT GRANTS: You must PROVIDE at least one of the Treatment Services numbered 1 through 4.]

1. Screening Shape165

2. Brief Intervention Shape166

3. Brief Treatment Shape167

4. Referral to Treatment Shape168

5. Assessment Shape169

6. Treatment Planning Shape170

7. Recovery Planning Shape171

8. Individual Counseling Shape172

9. Group Counseling Shape173

10. Contingency Management Shape174

11. Community Reinforcement Shape175

12. Cognitive Behavioral Therapy Shape176

13. Family/Marriage Counseling Shape177

14. Co-Occurring Treatment Services Shape178

15. Pharmacological Interventions Shape179

16. HIV/AIDS Counseling Shape180

17. Cultural Interventions/Activities Shape181

18. Other Clinical Services
(Specify) Shape182

Case Management Services

1. Family Services (E.g. Marriage Education, Parenting, Child Development Services) Shape183

2. Child Care Shape184

3. Employment Service

A. Pre-Employment Shape185

B. Employment Coaching Shape186

4. Individual Services Coordination Shape187

5. Transportation Shape188

6. HIV/AIDS Services

A. If HIV Neg, Pre-Exposure Prophylaxis Shape189

B. If HIV Neg, Post-Exposure Prophylaxis Shape190

C. If HIV Positive, HIV Treatment Shape191

7. Transitional Drug-Free Housing Services Shape192

8. Housing Support Shape193

9. Health Insurance Enrollment Shape194

10. Other Case Management Services
(Specify) Shape195

Medical Services

1. Medical Care Shape196

2. Alcohol/Drug Testing Shape197

3. OB/GYN Services Shape198

4. HIV/AIDS Medical Support & Testing Shape199

5. Dental Care Shape200

6. Viral Hepatitis Medical Support & Testing Shape201

7. Other STI Support & Testing Shape202

8. Other Medical Services
(Specify) Shape203

After Care Services

1. Continuing Care Shape204

2. Relapse Prevention Shape205

3. Recovery Coaching Shape206

4. Self-Help and Mutual Support Groups Shape207

5. Spiritual Support Shape208

6. Other After Care Services
(Specify) Shape209

Education Services

1. Substance Use Education Shape210

2. HIV/AIDS Education Shape211

3. Naloxone Training Shape212

4. Fentanyl Test Strip Training Shape213

5. Viral Hepatitis Education Shape214

6. Other STI Education Services Shape215

7. Other Education Services
(Specify) Shape216

Recovery Support Services

1. Peer Coaching or Mentoring Shape217

2. Vocational Services Shape218

3. Recovery Housing Shape219

4. Recovery Planning Shape220

5. Case Management Services to Specifically Support Recovery Shape221

6. Alcohol- and Drug-Free Social Activities Shape222

7. Information and Referral Shape223

8. Other Recovery Support Services (Specify)_________________________ Shape224

9. Other Peer-to-Peer Recovery Support Services (Specify) Shape225

C. Living Conditions

  1. In the past 30 days, where have you been living most of the time? [DO NOT READ RESPONSE OPTIONS TO CLIENT.]

Shape226 Shelter (Safe Havens, Transitional Living Center [TLC], Low-Demand Facilities, Reception Centers, Other Temporary Day or Evening Facility)

Shape227 Street/Outdoors (Sidewalk, Doorway, Park, Public Or Abandoned Building)

Shape228 Institution (Hospital, Nursing Home, Jail/Prison)

Shape229 Housed: [IF HOUSED, CHECK APPROPRIATE SUBCATEGORY:]

Shape230 Own/Rental Apartment, Room, Trailer, Or House

Shape231 Someone Else’s Apartment, Room, Trailer, Or House (including couch surfing)

Shape232 Dormitory/College Residence

Shape233 Halfway House or Transitional Housing

Shape234 Residential Treatment

Shape235 Recovery Residence/Sober Living

Shape236 Other Housed (Specify)

Shape237 Refused

  1. Do you currently live with any person who, over the past 30 days, has regularly used alcohol or other substances?

Shape238 Yes

Shape239 No

Shape240 No, lives alone

Shape241 Refused



D. Education, Employment, and Income

  1. Are you currently enrolled in school or a job training program? [IF ENROLLED] Is that full time or part time? [IF CLIENT IS INCARCERATED, CODE D1 AS “NOT ENROLLED.”]

Shape242 Not Enrolled

Shape243 Enrolled, Full Time

Shape244 Enrolled, Part Time

Shape245 Refused

  1. What is the highest level of education you have finished, whether or not you received a degree?

Shape246 Less than 12th Grade

Shape247 12th Grade/High School Diploma/Equivalent

Shape248 Vocational/Technical (Voc/Tech) Diploma

Shape249 Some College or University

Shape250 Bachelor’s Degree (For example: BA, BS)

Shape251 Graduate Work/Graduate Degree

Shape252 Other (Specify)____________________________________

Shape253 Refused


  1. Are you currently employed? [CLARIFY BY FOCUSING ON STATUS DURING MOST OF THE PREVIOUS WEEK, DETERMINING WHETHER CLIENT WORKED AT ALL OR HAD A REGULAR JOB BUT WAS OFF WORK.] [IF CLIENT IS INCARCERATED AND HAS NO WORK OUTSIDE OF JAIL, CODE D3 AS “NOT LOOKING FOR WORK.”]

Shape254 Employed, Full Time (35+ Hours Per Week, Or Would Be, If Not For Leave or An Excused Absence)

Shape255 Employed, Part Time

Shape256 Unemployed—But Looking For Work

Shape257 Not Employed, NOT Looking For Work

Shape258 Not working due to a disability

Shape259 Retired, not working

Shape260 Other (Specify)

Shape261 Refused

4. Do you, individually, have enough money to pay for the following living expenses? Choose all that apply.

Shape262 Food

Shape263 Clothing

Shape264 Transportation

Shape265 Rent/Housing

Shape266 Utilities (Gas/Water/Electric)

Shape267 Telephone Connection (Cell or Landline)

Shape268 Childcare

Shape269 Health Insurance

Shape270 Refused









5. What is your personal annual income, meaning the total pre-tax income from all sources, earned in the past year?

Shape271 $0 to $9,999

Shape272 $10,000 to $14,999

Shape273 $15,000 to $19,999

Shape274 $20,000 to $34,999

Shape275 $35,000 to $49,999

Shape276 $50,000 to $74,999

Shape277 $75,000 to $99,999

Shape278 $100,000 to $199,999

Shape279 $200,000 or more

Shape280 Refused



































E. Legal

  1. In the past 30 days, how many times have you been arrested? [IF THE CLIENT INDICATES NO ARRESTS IN THE PAST 30 DAYS, BUT IS INCARCERATED AT THE TIME OF THE INTERVIEW, MARK CURRENTLY INCARCERATED]



|____|____| times Shape281  REFUSED Shape282 Currently Incarcerated

  1. Are you currently awaiting charges, trial, or sentencing?

Shape283 Yes

Shape284 No

Shape285 Refused

  1. Are you currently on parole or probation or intensive pretrial supervision?

Shape286 Probation

Shape287 Parole

Shape288 Intensive Pretrial Supervision

Shape289 No

Shape290 Refused

  1. Do you currently participate in a drug court program or are you in a deferred prosecution agreement?

Shape291 Drug court program

Shape292 Deferred prosecution agreement

Shape293 No, neither of these

Shape294 Refused



























F. MENTAL AND PHYSICAL HEALTH PROBLEMS AND TREATMENT/RECOVERY

1. How would you rate your quality of life over the past 30 days?

Shape295 Very poor

Shape296 Poor

Shape297 Neither poor nor good

Shape298 Good

Shape299 Very good

Shape300 Refused

2. In the past 30 days, how many days have you [ENTER ‘O’ IN DAYS REPORTS THAT THEY HAVE NOT EXPIF THE CLIENT ERIENCED THE CONDITION. SELECT REFUSED FOR NO RESPONSE]:

Days Refused

2a. Experienced serious depression |____|____| Shape301

2b. Experienced serious anxiety or tension |____|____| Shape302

2c. Experienced hallucinations |____|____| Shape303

2d. Experienced trouble understanding, concentrating, or remembering |____|____| Shape304

2e. Experienced trouble controlling violent behavior |____|____| Shape305

2f. Attempted suicide |____|____| Shape306

2g. Been prescribed medication for psychological/emotional problem |____|____| Shape307

[IF CLIENT REPORTS 1 OR MORE DAYS TO ANY QUESTION IN #2, PLEASE ENSURE THAT THEY ARE SEEN BY A LICENSED PROFESSIONAL AS SOON AS POSSIBLE.]

3. How much have you been bothered by these psychological or emotional problems in the past 30 days?

Shape308 Not at all

Shape309 Slightly

Shape310 Moderately

Shape311 Considerably

Shape312 Extremely

Shape313 No reported mental health complaints in the past 30 days

Shape314 Refused

4. In the past 30 days, where have you gone to receive medical care? You may select more than one response.

Shape315 Primary Care Provider

Shape316 Urgent Care

Shape317 The Emergency Department

Shape318 A specialist doctor

Shape319 No care was sought

Shape320 Other (SPECIFY) _____________________________







  1. Do you currently have medical/health insurance?

Shape321 Yes

Shape322 No [GO TO NEXT SECTION]

Shape323 Refused [GO TO NEXT SECTION]

5a. What type of insurance do you have [CHECK all that apply]?

Shape324 Medicare

Shape325 Medicaid

Shape326 Private Insurance or Employer Provided

Shape327 TRICARE or other military health care

Shape328 An assistance program [for example, a medication assistance program]

Shape329 Any other type of health insurance or health coverage plan (Specify)______________________

Shape330 Refused































G. Social Connectedness

  1. In the past 30 days, did you attend any voluntary mutual support groups for recovery? In other words, did you participate in a non-professional, peer-operated organization that assists individuals who have addiction-related problems such as: Alcoholics Anonymous, Narcotics Anonymous, Secular Organization for Sobriety, Women for Sobriety, religious/faith-affiliated recovery mutual support groups, etc.? Attendance could have been in person or virtual.

Shape331 Yes [IF YES] Specify How Many Times |____|____| Shape332  Refused

Shape333 No

Shape334 Refused

  1. In the past 30 days, did you have interaction with family and/or friends that are supportive of your recovery?

Shape335 Yes

Shape336 No

Shape337 Refused

  1. How satisfied are you with your personal relationships?

Shape338 Very Dissatisfied

Shape339 Dissatisfied

Shape340 Neither Satisfied nor Dissatisfied

Shape341 Satisfied

Shape342 Very Satisfied

Shape343 Refused

  1. In the past 30 days did you realize that you need to change those social connections or places that negatively impact your recovery?

Shape344 Yes

Shape345 No

Shape346 Refused



H. PROGRAM SPECIFIC QUESTIONS: YOU ARE NOT RESPONSIBLE FOR COLLECTING DATA ON ALL SECTION H QUESTIONS. YOUR GPO HAS PROVIDED YOU WITH GUIDANCE ON WHICH SPECIFIC SECTION H QUESTIONS YOU ARE TO COMPLETE. IF YOU HAVE ANY QUESTIONS, PLEASE CONTACT YOUR GPO.

H1. PROGRAM SPECIFIC QUESTIONS


[QUESTION 1 SHOULD BE REPORTED BY GRANTEE STAFF AT FOLLOW-UP AND DISCHARGE]

  1. Which of the following occurred for the client, subsequent to receiving treatment? [CHECK ALL THAT APPLY.]

Shape347 Client was reunited with child (or children)

1a. With Agency Supervision Shape348

1b. Without Agency Supervision Shape349

Shape350 Client avoided out of home placement for child (or children)

Shape351 None of the above







H2. PROGRAM SPECIFIC QUESTIONS

[QUESTION 1 SHOULD BE ANSWERED BY THE CLIENT AT FOLLOW-UP AND DISCHARGE]


  1. Did the [insert grantee name] help you obtain any of the following benefits? [CHECK ALL THAT APPLY.]

Shape352 Private Health Insurance

Shape353 Medicaid

Shape354 Medicare

Shape355 SSI/SSDI

Shape356 TANF

Shape357 SNAP

Shape358 Other (Specify)

Shape359 None of the above

Shape360 Refused







H3. PROGRAM SPECIFIC QUESTIONS

[QUESTION 1 SHOULD BE ANSWERED BY THE CLIENT AT FOLLOW-UP AND DISCHARGE.]

1. Have you achieved any of the following since you began receiving services or supports from [insert grantee name]? If yes, Do you believe that the services you received from [insert grantee name] helped you with this achievement?


Achieved?

[If yes], Do you believe that the services you received from [insert grantee name] helped you with this achievement?

1a. Enrolled in school

Shape361 Yes

Shape362 No

Shape363 Refused

Shape364 Yes

Shape365 No

Shape366 Refused

1b. Enrolled in vocational training

Shape367 Yes

Shape368 No

Shape369 Refused

Shape370 Yes

Shape371 No

Shape372 Refused

1c. Currently employed


Shape373 Yes

Shape374 No

Shape375 Refused

Shape376 Yes

Shape377 No

Shape378 Refused

1d. Living in stable housing


Shape379 Yes

Shape380 No

Shape381 Refused

Shape382 Yes

Shape383 No

Shape384 Refused

















H4. PROGRAM SPECIFIC QUESTIONS

[QUESTION 1 SHOULD BE ANSWERED BY THE CLIENT AT FOLLOW-UP AND DISCHARGE]

  1. Please indicate the degree to which you agree or disagree with the following statements:

1a. Receiving treatment in a non-residential setting has enabled me to maintain parenting and family responsibilities while receiving treatment.

Shape385 Strongly disagree

Shape386 Disagree

Shape387 Undecided

Shape388 Agree

Shape389 Strongly Agree

Shape390 REFUSED

1b. As a result of treatment, I feel I now have the skills and support to balance parenting and managing my recovery.

Shape391 Strongly disagree

Shape392 Disagree

Shape393 Undecided

Shape394 Agree

Shape395 Strongly Agree

Shape396 Refused


H5. PROGRAM SPECIFIC QUESTIONS

[QUESTION 1 SHOULD BE ANSWERED BY THE CLIENT AT FOLLOW-UP AND DISCHARGE]


  1. Please indicate the degree to which you agree or disagree with the following statements:

1a. Receiving treatment in a residential setting without my child (or children) has enabled me to focus on my treatment without distractions of parenting and family responsibilities.

Shape397 Strongly disagree

Shape398 Disagree

Shape399 Undecided

Shape400 Agree

Shape401 Strongly Agree

Shape402 Refused

1b. As a result of treatment, I feel I now have the skills and support to balance parenting and managing my recovery.

Shape403 Strongly disagree

Shape404 Disagree

Shape405 Undecided

Shape406 Agree

Shape407 Strongly Agree

Shape408 Refused



H6. PROGRAM SPECIFIC QUESTIONS

[QUESTION 1 SHOULD BE REPORTED BY GRANTEE STAFF AT INTAKE/BASELINE, FOLLOW-UP, AND DISCHARGE.]


  1. Please indicate which type of funding was/will be used to pay for the SBIRT services provided to this client. [CHECK ALL THAT APPLY.]


Shape409 Current SAMHSA grant funding

Shape410 Other federal grant funding

Shape411 State funding

Shape412 Client’s private insurance

Shape413 Medicaid/Medicare

Shape414 TRICARE

Shape415 Other (Specify)____________________


[IF FOLLOW-UP OR DISCHARGE INTERVIEW, SKIP TO QUESTION 6.]


[QUESTIONS 2-5 SHOULD BE REPORTED BY GRANTEE STAFF ONLY AT INTAKE/BASELINE.]


  1. When the SBIRT was administered, how did the client screen?


Shape416 Negative

Shape417 Positive


  1. What was screening score?their


3a. ) AUDIT(Alcohol Use Disorders Identification Test

=

|____|____|

3b. CAGE

=

|____|____|

3c. ) DAST(Drug Abuse Screening Test

=

|____|____|

3d. DAST-10

=

|____|____|

3e. National Institute on Alcohol Abuse and Alcoholism (NIAAA) Guide

=

|____|____|

3f. SubscoreAlcohol, Smoking and Substance Involvement Screening Test (ASSIST)/Alcohol

=

|____|____|

3g. Other ) (Specify

=

|____|____|

______________________________________

______________________________________

______________________________________

  1. W?servicesparticipation in SBIRT theirwilling to continue e they er


Shape418 Yes

Shape419 No






  1. If the client screened positive for substance misuse or a substance use disorder, was the client assigned to the following types of services? [IF CLIENT SCREENED NEGATIVE, SELECT “NO” FOR EACH SERVICE BELOW.]


Yes

No

5a. Brief Intervention

Shape420

Shape421

5b. Brief Treatment

Shape422

Shape423

5c. Referral to Treatment

Shape424

Shape425



[QUESTION 6 SHOULD BE REPORTED BY GRANTEE STAFF AT INTAKE/BASELINE, FOLLOW-UP AND DISCHARGE.]

  1. Did the client receive the following types of services?


Yes

No

6a. Brief Intervention

Shape426

Shape427

6b. Brief Treatment

Shape428

Shape429

6c. Referral to Treatment

Shape430

Shape431














H7. PROGRAM SPECIFIC QUESTIONS

[ALL H7 QUESTIONS SHOULD BE ANSWERED BY THE CLIENT AT INTAKE/BASELINE, FOLLOW-UP AND DISCHARGE.]


1. In the past 30 days, have you been sexually active?

Shape432 Yes

Shape433 No [SKIP TO QUESTION 2]

Shape434 Not Permitted To Ask [SKIP TO QUESTION 2]

Shape435 Refused [SKIP TO QUESTION 2]

Altogether, in the past 30 days, how many: Response Refused

1a. Sexual partners did you have? Number: |____|____|____| Shape436

1b. Did you engage in unprotected/condomless sex?

Shape437 Yes

Shape438 No → [SKIP TO QUESTION 2]

1c. Were any of your partners:

1. Living with HIV and not taking HIV medications Shape439 Yes Shape440 No Shape441

2. A person who injects drugs Shape442 Yes Shape443 No Shape444

3. High on one or more substances Shape445 Yes Shape446 No Shape447

2. Are you currently taking Pre-Exposure Prophylaxis (PrEP) for HIV prevention, or are you taking medication for the treatment of HIV?

Shape448 PrEP

Shape449 Treatment for HIV

Shape450 Neither

Shape451 Refused

  1. Did the program provide access to the following?

3a1. An HIV test?

Shape452 Yes

Shape453 No [SKIP TO QUESTION 3b1]

Shape454 Refused [SKIP TO QUESTION 3b1]

3a2. Was this the first time that you had been tested for HIV?

Shape455 Yes

Shape456 No [SKIP TO QUESTION 3a5]

Shape457 Refused [SKIP TO QUESTION 3a5]

3a3. Was HIV testing performed on-site or were you referred out for testing?

Shape458 On-site [SKIP TO QUESTION 3a5]

Shape459 Referred out

Shape460 Refused [SKIP TO QUESTION 3a5]




3a4. Where was testing performed?

Shape461 Primary Care Provider’s office

Shape462 Dedicated clinic

Shape463 VA Medical Center

Shape464 Health Center or Community Clinic

Shape465 Local Health Department

Shape466 Specialty Addiction Treatment Program

Shape467 Sexual Health Center

Shape468 A mobile testing service

Shape469 Other (SPECIFY) _________________

3a5. What was the result?

Shape470 Positive

Shape471 Negative [SKIP TO QUESTION 3a12]

Shape472 Indeterminate

Shape473 Refused [SKIP TO QUESTION 3b1]

3a6. Did you receive confirmatory testing?

Shape474 Yes

Shape475 No [SKIP TO QUESTION 3a8]

Shape476 Refused [SKIP TO QUESTION 3a8]

3a7. What was the result?

Shape477 Positive

Shape478 Negative

Shape479 Indeterminate

Shape480 Refused

3a8. Were you connected to HIV treatment services within 30 days of the positive test result?


Shape481 Yes

Shape482 No [SKIP TO QUESTION 3a10]

Shape483 Refused [SKIP TO QUESTION 3a10]

3a9. Where were you referred for ongoing treatment?

Shape484 Primary Care Provider’s office

Shape485 Dedicated clinic

Shape486 VA Medical Center

Shape487 Health Center or Community Clinic

Shape488 Local Health Department

Shape489 Specialty Addiction Treatment Program

Shape490 Sexual Health Center

Shape491 Other (SPECIFY) _________________

3a10. Was rapid HIV testing offered to your substance-using and/or sexual partners?

Shape492 Yes

Shape493 No [SKIP TO QUESTION 3b1]

Shape494 Refused [SKIP TO QUESTION 3b1]



3a11. What was the number of drug-using and/or sexual partners offered HIV testing?

Shape495 1 []SKIP TO QUESTION 3b1

Shape496 2 []SKIP TO QUESTION 3b1

Shape497 3 []SKIP TO QUESTION 3b1

Shape498 4 or more []SKIP TO QUESTION 3b1

Shape499 Refused []SKIP TO QUESTION 3b1

3a12. Were you referred for Pre-Exposure Prophylaxis (PrEP) or Post-Exposure Prophylaxis (PEP), and/or were you referred for counseling about these interventions? [Select all that apply]

Shape500 PrEP

Shape501 PEP

Shape502 Received Counseling

Shape503 Did not receive medications

Shape504 Did not receive counseling

Shape505 Refused

3b1. Did you receive a Rapid Hepatitis C (HCV) test?

Shape506 Yes

Shape507 No [SKIP TO QUESTION 3c1]

Shape508 Refused [SKIP TO QUESTION 3c1]

3b2. Was this test followed up with confirmatory Hepatitis C (HCV RNA) testing?

Shape509 Yes

Shape510 No

3b3. What was the result of your HCV test?

Shape511 Positive

Shape512 Negative [SKIP TO QUESTION 3c1]

Shape513 Indeterminate

Shape514 Refused [SKIP TO QUESTION 3c1]

3b4. Were you connected to Hepatitis C treatment

services?


Shape515 Yes

Shape516 No

Shape517 Refused

3c1. Did you receive a Hepatitis B (HBV) test?

Shape518 Yes

Shape519 No [SKIP TO QUESTION 3d1]

Shape520 Refused [SKIP TO QUESTION 3d1]

3c2. What was the result of your HBV test?

Shape521 Positive

Shape522 Negative [SKIP TO QUESTION 3d1]

Shape523 Indeterminate

Shape524 Refused [SKIP TO QUESTION 3d1]


3c3. Were you connected to Hepatitis B treatment services?



Shape525 Yes

Shape526 No

Shape527 Refused

3d1. Was the client offered a Hepatitis A and B Vaccination?

Shape528 Yes [GO TO SECTION I OR J/K]

Shape529 No

Shape530 Refused [GO TO SECTION I OR J/K]

3d2. Was the client referred out for vaccination?

Shape531 Yes

Shape532 No

Shape533 Refused


H8. PROGRAM SPECIFIC QUESTIONS [QUESTIONS 1, 2 And 3 SHOULD BE ANSWERED BY THE CLIENT AT FOLLOW-UP AND DISCHARGE]

  1. Is peer support available at this program?

Shape534 Yes

Shape535 No [SKIP TO QUESTION 3]

  1. Have you achieved any of the following since you began receiving peer services from [insert grantee name]? [If yes], Do you believe that the services you received from [insert grantee name] helped you with this achievement?


Achieved?

[If yes], Do you believe that the services you received from [insert grantee name] helped you with this achievement?

2a. Enrolled in school

Shape536 Yes

Shape537 No

Shape538 Refused

Shape539 Yes

Shape540 No

Shape541 Refused

2b. Enrolled in vocational training

Shape542 Yes

Shape543 No

Shape544 Refused

Shape545 Yes

Shape546 No

Shape547 Refused

2c. Currently employed


Shape548 Yes

Shape549 No

Shape550 Refused

Shape551 Yes

Shape552 No

Shape553 Refused

2d. Living in stable housing

Shape554 Yes

Shape555 No

Shape556 Refused

Shape557 Yes

Shape558 No

Shape559 Refused


  1. To what extent has this program improved your quality of life?

Shape560 To a great extent

Shape561 Somewhat

Shape562 Very little

Shape563 Not at all

Shape564 Refused











H9. PROGRAM SPECIFIC QUESTIONS

[QUESTION 1 SHOULD BE ANSWERED BY THE CLIENT AT FOLLOW-UP AND DISCHARGE]



  1. Please indicate the degree to which you agree or disagree with the following statements:




1a. The use of technology accessed through [insert grantee name] has helped me communicate with my provider.



Shape565 Strongly disagree

Shape566 Disagree

Shape567 Undecided

Shape568 Agree

Shape569 Strongly Agree

Shape570 Not Applicable

Shape571 Refused


1b. The use of technology accessed through [insert grantee name] has helped me reduce my substance use.



Shape572 Strongly disagree

Shape573 Disagree

Shape574 Undecided

Shape575 Agree

Shape576 Strongly Agree

Shape577 Not Applicable

Shape578 Refused


1c. The use of technology accessed through [insert grantee name] has helped me manage my mental health symptoms.



Shape579 Strongly disagree

Shape580 Disagree

Shape581 Undecided

Shape582 Agree

Shape583 Strongly Agree

Shape584 Not Applicable

Shape585 Refused


1d. The use of technology accessed through [insert grantee name] has helped me support my recovery.



Shape586 Strongly disagree

Shape587 Disagree

Shape588 Undecided

Shape589 Agree

Shape590 Strongly Agree

Shape591 Not Applicable

Shape592 Refused

H10. PROGRAM SPECIFIC QUESTIONS

[QUESTIONS 1 AND 1 aSHOULD BE REPORTED BY GRANTEE STAFF AT INTAKE/BASELINE, FOLLOW-UP, AND DISCHARGE]

[QUESTION 1 bSHOULD BE REPORTED BY GRANTEE STAFF AT FOLLOW-UP/DISCHARGE IF THE CLIENT HAS BEEN REFERRED FOR SERVICES]


  1. Did the client screen positive for, or have a history of, a mental health disorder?

Shape593 Client screened positive

Shape594 Client screened negative [SKIP TO QUESTION 2]

Shape595 Client was not screened [SKIP TO QUESTION 2]

Shape596 Client has a positive history

1a. Was the client referred to mental health services?

Shape597 Yes ]SKIP TO QUESTION 2 IF INTAKE/BASELINE; ANSWER 1b IF FOLLOW-UP/DISCHARGE[

Shape598 No [SKIP TO QUESTION 2]


1b. Did the client receive mental health services?

Shape599 Yes

Shape600 No


[QUESTIONS 2 AND 2a SHOULD BE REPORTED BY GRANTEE STAFF AT INTAKE/BASELINE, FOLLOW-UP, AND DISCHARGE]

[QUESTION 2b SHOULD BE REPORTED BY GRANTEE STAFF AT FOLLOW-UP/DISCHARGE IF THE CLIENT HAS BEEN REFERRED FOR SERVICES]


  1. Did the client screen positive for, or have a history of, substance use disorder(s)?

Shape601 Client screened positive

Shape602 Client screened negative [SKIP TO QUESTION 3 IF FOLLOW-UP/DISCHARGE]

Shape603 Client was not screened [SKIP TO QUESTION 3 IF FOLLOW-UP/DISCHARGE]

Shape604 Client has a positive history


2a. Was the client referred to substance use disorder services?

Shape605 Yes [ANSWER 2b IF FOLLOW-UP/DISCHARGE]

Shape606 No [SKIP TO QUESTION 3 IF FOLLOW-UP/DISCHARGE]


[IF THIS IS AN INTAKE/BASELINE, SECTION H10 IS DONE.]


2b. Did the client receive substance use disorder services?

Shape607 Yes

Shape608 No





Shape609

H10. PROGRAM SPECIFIC QUESTIONS (continued)


[QUESTION 3 SHOULD BE ANSWERED BY THE CLIENT AT FOLLOW-UP AND DISCHARGE]

  1. Please indicate the degree to which you agree or disagree with the following statement: Receiving community-based services through [insert grantee name] has helped me to avoid further contact with the police and the criminal justice system.

Shape610 Strongly disagree

Shape611 Disagree

Shape612 Undecided

Shape613 Agree

Shape614 Strongly Agree

Shape615 Refused





































































I. Follow-Up Status

[REPORTED BY PROGRAM STAFF ABOUT CLIENT ONLY AT FOLLOW-UP.]

  1. Was the client able to be contacted for follow-up?

Shape616 Yes

Shape617 No

2. What is the follow-up status of the client? [THIS IS A REQUIRED FIELD: NA, REFUSED, DON’T KNOW, AND MISSING WILL NOT BE ACCEPTED.]

Shape618 01 = Deceased at time of due date

Shape619 11 = Completed interview within specified window

Shape620 12 = Completed interview outside specified window

Shape621 21 = Located, but Refused, unspecified

Shape622 22 = Located, but unable to gain institutional access

Shape623 23 = Located, but otherwise unable to gain access

Shape624 24 = Located, but withdrawn from project

Shape625 31 = Unable to locate, moved

Shape626 32 = Unable to locate, other (Specify) ________________________


3. Is the client still receiving services from your program?

Shape627 Yes

Shape628 No



Please complete Sections B, C, D, E, F, G and those sections of Section H assigned to your program.


[IF THIS IS A FOLLOW-UP INTERVIEW, STOP NOW; THE INTERVIEW IS COMPLETE.]

J. Discharge Status [REPORTED BY PROGRAM STAFF ABOUT CLIENT ONLY AT DISCHARGE.]

  1. On what date was the client discharged?

|____|____| / |____|____| / |____|____|____|____|
Month Day Year

  1. What is the client’s discharge status?

Shape629 01 = Completion/Graduate [SKIP TO QUESTION 3]

Shape630 02 = Termination

2a. If the client was terminated, what was the reason for termination? [Select one response.]

Shape631 01 = Left on own against staff advice with satisfactory progress

Shape632 02 = Left on own against staff advice without satisfactory progress

Shape633 03 = Involuntarily discharged due to nonparticipation

Shape634 04 = Involuntarily discharged due to violation of rules

Shape635 05 = Referred to another program or other services with satisfactory progress

Shape636 06 = Referred to another program or other services with unsatisfactory progress

Shape637 07 = Incarcerated due to offense committed while in treatment/recovery with satisfactory progress

Shape638 08 = Incarcerated due to offense committed while in treatment/recovery with unsatisfactory progress

Shape639 09 = Incarcerated due to old warrant or charged from before entering treatment/recovery with satisfactory progress

Shape640 10 = Incarcerated due to old warrant or charged from before entering treatment/recovery with unsatisfactory progress

Shape641 11 = Transferred to another facility for health reasons

Shape642 12 = Death

Shape643 13 = Other (Specify)

  1. Did the program order an HIV test for this client?

Shape644 Yes [SKIP TO QUESTION 5]

Shape645 No

  1. Did the program refer this client for HIV testing with another provider?

Shape646 Yes

Shape647 No

  1. Did the program provide Naloxone and/or Fentanyl Test Strips to this client at any time during their involvement in grant funded services?

Shape648 Naloxone

Shape649 Fentanyl Test Strips

Shape650 Both Naloxone and Fentanyl Test Strips

Shape651 Neither

  1. Is the client fully vaccinated against the virus that causes COVID-19?

Shape652 Yes

Shape653 No, partially vaccinated with plans to receive the subsequent vaccination on time

Shape654 No, partially vaccinated with no plan to receive the subsequent vaccination

Shape655 No, client refused vaccination

Shape656 Refused to answer

K. Services Received UNDER GRANT fUNDING [REPORTED BY PROGRAM STAFF ONLY AT DISCHARGE.]


1. Identify the number of DAYS of services provided to the client during the client’s course of treatment/recovery. [ENTER ZERO IF NO SERVICES PROVIDED. YOU SHOULD HAVE AT LEAST ONE DAY FOR MODALITY.]


Modality Days

1. Case Management |___|___|___|

2. Intensive Outpatient Treatment |___|___|___|

3. Inpatient/Hospital (Other Than Withdrawal Management) |___|___|___|

4. Outpatient Therapy |___|___|___|

5. Outreach |___|___|___|

6. Medication

A. Methadone |___|___|___|

B. Buprenorphine |___|___|___|

C. Naltrexone – Short Acting |___|___|___|

D. Naltrexone – Long Acting (Report

28 days for each one injection) |___|___|___|

E. Disulfiram |___|___|___|

F. Acamprosate |___|___|___|

G. Nicotine Replacement |___|___|___|

H. Bupropion |___|___|___|

I. Varenicline |___|___|___|

7. Residential/Rehabilitation |___|___|___|

8. Withdrawal Management (Select Only 1):

A. Hospital Inpatient |___|___|___|

B. Free Standing Residential |___|___|___|

C. Ambulatory Detoxification |___|___|___|

9. After Care |___|___|___|

10. Recovery Support |___|___|___|

11. Other (Specify) |___|___|___|

Identify the number of SESSIONS provided to the client during the client’s course of treatment/‌recovery. [ENTER ZERO IF NO SERVICES PROVIDED. YOU SHOULD HAVE AT LEAST ONE SESSION IN ONE SERVICE CATEGORY.]

Treatment Services Sessions

[SBIRT GRANTS: You must have at least one session for one of the Treatment Services numbered 1 through 4.]

1. Screening |___|___|___|

2. Brief Intervention |___|___|___|

3. Brief Treatment |___|___|___|

4. Referral to Treatment |___|___|___|

5. Assessment |___|___|___|

6. Treatment Planning |___|___|___|

7. Recovery Planning |___|___|___|

8. Individual Counseling |___|___|___|

9. Group Counseling |___|___|___|

10. Contingency Management |___|___|___|

11. Community Reinforcement |___|___|___|

12. Cognitive Behavioral Therapy |___|___|___|

13. Family/Marriage Counseling |___|___|___|

14. Co-Occurring Treatment Services |___|___|___|

15. Pharmacological Interventions |___|___|___|

16. HIV/AIDS Counseling |___|___|___|

17. Cultural Interventions/Activities |___|___|___|

18. Other Clinical Services
(Specify) |___|___|___|

Case Management Services Sessions

1. Family Services (E.g Marriage Education, Parenting, Child Development Services) |___|___|___|

2. Child Care |___|___|___|

3. Employment Service

A. Pre-Employment |___|___|___|

B. Employment Coaching |___|___|___|

4. Individual Services Coordination |___|___|___|

5. Transportation |___|___|___|

6. HIV/AIDS Services & Counseling |___|___|___|

7. Transitional Drug-Free Housing Services |___|___|___|

8. Housing Support |___|___|___|

9. Health Insurance Enrollment |___|___|___|

10. Other Case Management Services

(Specify) |___|___|___|

Medical Services Sessions

1. Medical Care |___|___|___|

2. Alcohol/Drug Testing |___|___|___|

3. OB/GYN Services |___|___|___|

4. HIV/ AIDS Medical Support & Testing |___|___|___|

5. Hepatitis Medical Support & Testing |___|___|___|

6. Other STI Support and Testing |___|___|___|

7. Dental Care |___|___|___|

8. Other Medical Services
(Specify) |___|___|___|

After Care Services Sessions

1. Continuing Care |___|___|___|

2. Relapse Prevention |___|___|___|

3. Recovery Coaching |___|___|___|

4. Self-Help and Mutual Support Groups |___|___|___|

5. Spiritual Support |___|___|___|

6. Other After Care Services
(Specify) |___|___|___|

Education Services Sessions

1. Substance Misuse Education |___|___|___|

2. HIV/AIDS Education |___|___|___|

3. Hepatitis Education |___|___|___|

4. Other STI Education Services |___|___|___|

5. Naloxone Training |___|___|___|

6. Fentanyl Test Strip Training |___|___|___|

7. Other Education Services
(Specify) |___|___|___|

Recovery Support Services Sessions

1. Peer Coaching or Mentoring |___|___|___|

2. Vocational Services |___|___|___|

3. Recovery Housing |___|___|___|

4. Recovery Planning |___|___|___|

5. Case Management Services to Specifically Support Recovery |___|___|___|

6. Alcohol- and Drug-Free Social Activities |___|___|___|

7. Information and Referral |___|___|___|

8. Other Recovery Support Services

(Specify) _________________________ |___|___|___|

9. Other Peer-to-Peer Recovery Support Services (Specify) |___|___|___|

  1. Has this client attended 60% or more of their planned services?

Shape657 Yes

Shape658 No

  1. Did this client receive any services via telehealth or a virtual platform?

Shape659 Yes

Shape660 No

  1. Has this client previously been diagnosed with an opioid use disorder?

Shape661 Yes

Shape662 No [SKIP TO QUESTION 5]

4a. In the past 30 days, which FDA-approved medication did the client receive for the treatment of this opioid use disorder? [CHECK ALL THAT APPLY.]

Shape663 Methadone

[IF RECEIVED]

Specify how many days received

|___|___|

Shape664 Buprenorphine

[IF RECEIVED]

Specify how many days received

|___|___|

Shape665 Naltrexone

[IF RECEIVED]

Specify how many days received

|___|___|

Shape666 Extended‒release Naltrexone

[IF RECEIVED]

Specify how many doses received

|___|___|

Shape667 Client did not receive an FDA-approved medication for a diagnosed opioid use disorder [SKIP TO QUESTION 5]


4b. Has this client taken the medication as prescribed?

Shape668 Yes

Shape669 No

  1. Has this client previously been diagnosed with an alcohol use disorder?

Shape670 Yes

Shape671 No [SKIP TO QUESTION 6]

5a. In the past 30 days, which FDA-approved medication did the client receive for the treatment of this alcohol use disorder? [CHECK ALL THAT APPLY.]

Shape672 Naltrexone

[IF RECEIVED]

Specify how many days received

|___|___|

Shape673 Extended‒release Naltrexone

[IF RECEIVED]

Specify how many doses received

|___|___|

Shape674 Disulfiram

[IF RECEIVED]

Specify how many days received

|___|___|

Shape675 Acamprosate

[IF RECEIVED]

Specify how many days received

|___|___|

Shape676 Client did not receive an FDA-approved medication for an alcohol use disorder [SKIP TO QUESTION 6]

5b. Has this client taken the medication as prescribed?

Shape677 Yes

Shape678 No


  1. Has this client previously been diagnosed with a stimulant use disorder?

Shape679 Yes

Shape680 No [SKIP TO QUESTION 7]

6a. In the past 30 days, which interventions did the client receive for the treatment of this stimulant use disorder? [CHECK ALL THAT APPLY.]

Shape681 Contingency Management

[IF RECEIVED]

Specify how many days received

|___|___|

Shape682 Community Reinforcement

[IF RECEIVED]

Specify how many days received

|___|___|

Shape683 Cognitive Behavioral Therapy

[IF RECEIVED]

Specify how many days received

|___|___|

Shape684 Other treatment approach

[IF RECEIVED]

Specify how many days received

|___|___|

Shape685 Client did not receive any intervention for a stimulant use disorder [SKIP TO QUESTION 7]

6b. Has this client attended and participated in interventions for stimulant use disorder?

Shape686 Yes

Shape687 No

  1. Has this client previously been diagnosed with a tobacco use disorder?

Shape688 Yes

Shape689 No [THE INTERVIEW IS DISCHARGE COMPLETE.]


7a. In the past 30 days, which FDA-approved medication did the client receive for the treatment of this tobacco use disorder? [CHECK ALL THAT APPLY.]

Shape690 Nicotine Replacement

[IF RECEIVED]

Specify how many days received

|___|___|

Shape691 Bupropion

[IF RECEIVED]

Specify how many days received

|___|___|

Shape692 Varenicline

[IF RECEIVED]

Specify how many days received

|___|___|

Shape693 Client did not receive an FDA-approved medication for a tobacco use disorder [THE DISCHARGE INTERVIEW IS COMPLETE.]

7b. Has this client taken the medication as prescribed?

Shape694 Yes

Shape695 No

[THE DISCHARGE INTERVIEW IS COMPLETE.]

File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
SubjectGovernment Performance and Results Act (GPRA) - Client Outcome Measures for Discretionary Programs
AuthorCenter for Substance Abuse Treatment (CSAT)
File Modified0000-00-00
File Created2022-08-17

© 2024 OMB.report | Privacy Policy